Birdwatch Note Rating
2024-08-14 03:09:11 UTC - HELPFUL
Rated by Participant: 5F4EEE1DD77A98E7F680092249589B1F89A7089B6908AB50150DC666E64FCA73
Participant Details
Original Note:
The scholarly articles have report "...These results suggest that a third dose of BNT162b2 is safe, improves humoral immunity against SARS-CoV-2, and could be immunologically beneficial for cancer patients on active chemotherapy." : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004706/ A scientific study is needed NOT speculation
All Note Details